Market Movers
Pre-Market and After Hours Market Movers
-
Bitcoin Falls Back After Hot Inflation Data and Treasury Comments
Bitcoin (BTC-USD) fell more than 3% on Thursday following a hotter-than-expected U.S. Producer Price Index (PPI) report and comments from…
Read More » -
Stock Market Today: Stocks Waver as Hot PPI Reading Clouds Rate-Cut Optimism
U.S. stocks struggled on Thursday as a hotter-than-expected Producer Price Index (PPI) report for July dampened expectations of a bigger…
Read More » -
Disney Trades Down ESPN Stake To Secure NFL Network & Redzone—Can It Surpass Netflix’s Live-Sports Ambitions?
Disney agreed to swap a 10 percent stake in ESPN for full control of NFL Network and RedZone—a deal worth…
Read More » -
Avantor Faces Activist Fire: Why Engine Capital Wants It Sold Now!
Avantor has landed in the sights of Engine Capital, which has built a 3% stake and is now pressing the…
Read More » -
Intel’s NEX Spin-Out Faces A Game-Changer—Ericsson Steps Up
Intel’s freshly spun-off networking and edge business, NEX, is making waves after reports surfaced that Ericsson is in late-stage talks…
Read More » -
Ethereum Nears Record Highs as Investors Eye Long-Term Potential
Ethereum (ETH), the world’s second-largest cryptocurrency by market cap, has surged to a near record high, fueled by optimism from…
Read More » -
Is Amphenol’s $10.5 Billion Commscope Play The Next AI Goldmine—Or A Risky Gamble?
Amphenol has reignited Wall Street chatter by edging toward a $10.5 billion deal for CommScope’s CCS broadband connectivity & cable…
Read More » -
Stock Market Today: Dow Surges as Fed Rate Cut Expectations Drive Gains
U.S. stocks rose on Wednesday, led by the Dow, as investors grew confident that the Federal Reserve may lower interest…
Read More » -
HNI’s Bold $2.2 Billion Steelcase Gambit: A New Chapter In The Office Furniture Market?
HNI's announcement that it will acquire Steelcase in a $2.2 billion cash-and-stock deal has catalyzed intense debate among investors and…
Read More » -
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share,…
Read More »
